Commentary by Sever, P et al.
Journal of the Renin-Angiotensin-
Aldosterone System
2015, Vol. 16(4) 701 
© The Author(s) 2015
Reprints and permissions: 
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/1470320315623658
jra.sagepub.com
Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons 
Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, 
reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open 
Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Earlier this year Biomed Central retracted 43 papers sub-
mitted by medical researchers in China due to their con-
cerns that the peer review process on these papers had 
been compromised by the supply of fabricated reviewers 
by either the authors or third-party agencies. This was 
reported in the Lancet (Volume 385, Issue 9976, 1365). 
Since then, there have been more retractions involving 
manipulation of the peer review process at other 
publishers.
JRAAS has conducted a systematic evaluation of papers 
in which acceptance was influenced by reviewers nomi-
nated by the authors. In a substantial number of cases (21 
identified during the course of this investigation), the 
Journal has established that although the nominated 
reviewers were real, their email addresses were falsified. 
We have traced the actual nominated reviewers and, where 
we received a response, those individuals have denied sub-
mitting a review of the relevant manuscript. This repre-
sents a clear case of identity fraud. Authorship was 
common to the majority of the papers.
Eight of these papers were published and have now 
been retracted by the journal. The remainder were being 
processed by the journal prior to publication and have now 
been rejected. All authors have been notified together with 
the institutions from which they were submitted. In several 
cases where the offending authors have published exten-
sively in other journals, the editors of those journals have 
been informed of our concerns about the manipulation of 
the peer review process.
The editors of JRAAS have taken the decision to imme-
diately suspend the use of author nominated reviewers. We 
would strongly urge other journal editors and their respec-
tive publishers to take similar actions. Forensic investiga-
tion reveals certain clues to fraudulent reviews including 
the use of non-institutional email addresses, email domains 
based in a country different from that of the named 
reviewer and the recurrent nomination of individuals from 
a “panel” of reviewers. The reviews are often brief, formu-
laic and contain common phrases despite apparently being 
from different reviewers.
As the Lancet pointed out, scientific fraud is a global 
concern and it is no doubt fuelled by the fact that many 
evaluation and promotion systems rely heavily on publica-
tion output. A wealth of outstanding science is conducted 
around the world and it is unfortunate that actions described 
here paint a very tarnished view of the scientific culture.
We are prepared to share our experience with other 
journal publishers if we can assist in eliminating this 
fraudulent practice which clearly is now far more wide-
spread than many believed.
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